BackBioPlus Acquisition Overview

BioPlus Acquisition Current Assets

Latest current assets for BIOS: $200K.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$196840.00
↓ 72.49% YoYΔ $-518698.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioPlus Acquisition Current Assets History

Loading

BioPlus Acquisition vs. peers: Current Assets Comparison

Loading

BioPlus Acquisition Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioPlus Acquisition (BIOS) FAQ

As of the most recent data (June 2023), BIOS shows a current assets of $200K. That compares with $720K in the prior-year period — down 72.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOS's current assets is now $200K (was $720K) — a 72.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioPlus Acquisition is outperforming or lagging.

Tracking BIOS's current assets over time shows whether BioPlus Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $200K That compares with $720K in the prior-year period — down 72.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has BioPlus Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $200K) with ownership activity and broader fundamentals.